133 related articles for article (PubMed ID: 17993764)
1. Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer.
Fiore E; Giustarini E; Mammoli C; Fragomeni F; Campani D; Muller I; Pinchera A; Giani C
J Endocrinol Invest; 2007 Oct; 30(9):734-8. PubMed ID: 17993764
[TBL] [Abstract][Full Text] [Related]
2. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery.
Giustarini E; Pinchera A; Fierabracci P; Roncella M; Fustaino L; Mammoli C; Giani C
Eur J Endocrinol; 2006 May; 154(5):645-9. PubMed ID: 16645010
[TBL] [Abstract][Full Text] [Related]
3. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy.
Giani C; Fierabracci P; Bonacci R; Gigliotti A; Campani D; De Negri F; Cecchetti D; Martino E; Pinchera A
J Clin Endocrinol Metab; 1996 Mar; 81(3):990-4. PubMed ID: 8772562
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of breast cancer in patients with benign thyroid diseases.
Muller I; Pinchera A; Fiore E; Belardi V; Rosellini V; Giustarini E; Giani C
J Endocrinol Invest; 2011 May; 34(5):349-52. PubMed ID: 20595798
[TBL] [Abstract][Full Text] [Related]
5. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
[TBL] [Abstract][Full Text] [Related]
6. Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues.
Fierabracci P; Pinchera A; Campani D; Pollina LE; Giustarini E; Giani C
J Endocrinol Invest; 2006 Mar; 29(3):248-51. PubMed ID: 16682839
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies.
Peluso R; Lupoli GA; Del Puente A; Iervolino S; Bruner V; Lupoli R; Di Minno MN; Foglia F; Scarpa R; Lupoli G
J Rheumatol; 2011 Jul; 38(7):1371-7. PubMed ID: 21498480
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
Nisman B; Allweis TM; Carmon E; Kadouri L; Maly B; Maimon O; Meierovich A; Peretz T
Anticancer Res; 2020 Nov; 40(11):6417-6428. PubMed ID: 33109580
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy.
Rago T; Di Coscio G; Ugolini C; Scutari M; Basolo F; Latrofa F; Romani R; Berti P; Grasso L; Braverman LE; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2007 Sep; 67(3):363-9. PubMed ID: 17555501
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
Loi S; Sirtaine N; Piette F; Salgado R; Viale G; Van Eenoo F; Rouas G; Francis P; Crown JP; Hitre E; de Azambuja E; Quinaux E; Di Leo A; Michiels S; Piccart MJ; Sotiriou C
J Clin Oncol; 2013 Mar; 31(7):860-7. PubMed ID: 23341518
[TBL] [Abstract][Full Text] [Related]
11. Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.
Fierabracci P; Pinchera A; Tonacchera M; Agretti P; De Marco G; Albertini S; Conforti G; Seregni E; Agresti R; Grasso L; Giani C
J Endocrinol Invest; 2004 Oct; 27(9):862-5. PubMed ID: 15648551
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
[TBL] [Abstract][Full Text] [Related]
14. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
17. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
[TBL] [Abstract][Full Text] [Related]
18. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
[TBL] [Abstract][Full Text] [Related]
19. Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
Watanabe T; Hida AI; Inoue N; Imamura M; Fujimoto Y; Akazawa K; Hirota S; Miyoshi Y
Breast Cancer Res Treat; 2018 Feb; 168(1):135-145. PubMed ID: 29168063
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of antithyroid peroxidase antibodies in patients with chronic autoimmune thyroiditis (Hashimoto's thyroiditis) treated with levothyroxine.
Schmidt M; Voell M; Rahlff I; Dietlein M; Kobe C; Faust M; Schicha H
Thyroid; 2008 Jul; 18(7):755-60. PubMed ID: 18631004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
